Hexagon Capital Partners’s Amedisys AMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-310
| Closed | -$28.7K | – | 155 |
|
|
2025
Q1 | $28.7K | Buy |
310
+161
| +108% | +$14.9K | 0.01% | 625 |
|
|
2024
Q4 | $13.5K | Buy |
149
+112
| +303% | +$10.2K | ﹤0.01% | 918 |
|
|
2024
Q3 | $3.57K | Sell |
37
-38
| -51% | -$3.67K | ﹤0.01% | 1116 |
|
|
2024
Q2 | $6.89K | Hold |
75
| – | – | ﹤0.01% | 952 |
|
|
2024
Q1 | $6.91K | Sell |
75
-15
| -17% | -$1.38K | ﹤0.01% | 938 |
|
|
2023
Q4 | $8.56K | Sell |
90
-18
| -17% | -$1.71K | ﹤0.01% | 861 |
|
|
2023
Q3 | $10.1K | Sell |
108
-56
| -34% | -$5.23K | ﹤0.01% | 745 |
|
|
2023
Q2 | $15K | Buy |
164
+19
| +13% | +$1.74K | ﹤0.01% | 640 |
|
|
2023
Q1 | $10.7K | Sell |
145
-83
| -36% | -$6.11K | ﹤0.01% | 718 |
|
|
2022
Q4 | $19K | Sell |
228
-82
| -26% | -$6.85K | 0.01% | 557 |
|
|
2022
Q3 | $30K | Sell |
310
-26
| -8% | -$2.52K | 0.01% | 493 |
|
|
2022
Q2 | $35K | Buy |
336
+3
| +0.9% | +$313 | 0.01% | 426 |
|
|
2022
Q1 | $57K | Buy |
333
+2
| +0.6% | +$342 | 0.02% | 347 |
|
|
2021
Q4 | $54K | Hold |
331
| – | – | 0.01% | 348 |
|
|
2021
Q3 | $49K | Sell |
331
-137
| -29% | -$20.3K | 0.01% | 348 |
|
|
2021
Q2 | $115K | Buy |
468
+12
| +3% | +$2.95K | 0.03% | 227 |
|
|
2021
Q1 | $120K | Sell |
456
-5
| -1% | -$1.32K | 0.03% | 196 |
|
|
2020
Q4 | $135K | Hold |
461
| – | – | 0.04% | 154 |
|
|
2020
Q3 | $117K | Buy |
+461
| New | +$117K | 0.04% | 159 |
|